BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20488715)

  • 1. Posterior reversible leukoencephalopathy due to "triple H" therapy.
    Jang HW; Lee HJ
    J Clin Neurosci; 2010 Aug; 17(8):1059-61. PubMed ID: 20488715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral posterior reversible encephalopathy syndrome with hypertensive therapy of contralateral vasospasm: case report.
    Dhar R; Dacey R; Human T; Zipfel G
    Neurosurgery; 2011 Nov; 69(5):E1176-81; E1181. PubMed ID: 21971491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior Reversible Encephalopathy Syndrome as an Overlooked Complication of Induced Hypertension for Cerebral Vasospasm: Systematic Review and Illustrative Case.
    Muhammad S; Güresir Á; Greschus S; Scorzin J; Vatter H; Güresir E
    Stroke; 2016 Feb; 47(2):519-22. PubMed ID: 26628389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which H is the most important in triple-H therapy for cerebral vasospasm?
    Treggiari MM; Deem S
    Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative hypertensive-hypervolaemic-haemodilution (Triple H) therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage.
    Gupta D; Sharma BS; Gupta SK; Bapuraj R; Khosla VK
    Neurol India; 2000 Jun; 48(2):126-31. PubMed ID: 10878775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
    Hunt MA; Bhardwaj A
    Crit Care Med; 2007 Aug; 35(8):1985-6. PubMed ID: 17667248
    [No Abstract]   [Full Text] [Related]  

  • 7. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm.
    Wartenberg KE; Parra A
    J Neuroimaging; 2006 Apr; 16(2):170-5. PubMed ID: 16629742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior reversible encephalopathy syndrome following hemodynamic treatment of aneurysmal subarachnoid hemorrhage-induced vasospasm.
    Awori J; Rajajee V; Gemmete JJ; Chaudhary N; Thompson BG; Pandey AS
    J Clin Neurosci; 2016 Apr; 26():33-6. PubMed ID: 26755456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The present role of "triple-H" therapy in the management of cerebral vasospasm.
    Findlay JM
    World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
    [No Abstract]   [Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome in a patient with HELLP syndrome complicating a triploid pregnancy.
    Vijayalakshmi B; Sethna F; Manford M; Lees CC
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):938-43. PubMed ID: 20632910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical reversible posterior leukoencephalopathy syndrome in a chronic haemodialysis patient with severe hypertension.
    Park J; Choi SH; Kwon JH; Chung HC; Lee JS
    Nephrology (Carlton); 2008 Dec; 13(6):542-3. PubMed ID: 19138210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage].
    Sato K; Tokairin H; Kato M
    Masui; 2001 Aug; 50(8):859-62. PubMed ID: 11554017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
    Doss-Esper CE; Singhal AB; Smith MS; Henderson GV
    J Neuroimaging; 2005 Apr; 15(2):188-92. PubMed ID: 15746232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible posterior leukoencephalopathy syndrome.
    Moon JM; Chun BJ
    J Emerg Med; 2010 Apr; 38(3):e1-4. PubMed ID: 18024064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension-induced reversible posterior leukoencephalopathy syndrome causing obstructive hydrocephalus.
    Lee SY; Dinesh SK; Thomas J
    J Clin Neurosci; 2008 Apr; 15(4):457-9. PubMed ID: 18249121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, May, 2003.
    Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
    J Neurosurg; 2004 Feb; 100(2):359-60; author reply 360. PubMed ID: 15086250
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura presenting with reversible posterior leukoencephalopathy syndrome.
    AOTA Y; KODAMA S; KITAGAWA N; KAWABATA S; GOTOH A; SAKURAI M
    Rinsho Ketsueki; 2009 Nov; 50(11):1652-4. PubMed ID: 20009443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome on computed tomography perfusion in a patient on "Triple H" therapy.
    Sanelli PC; Jacobs MA; Ougorets I; Mifsud MJ
    Neurocrit Care; 2005; 3(1):46-50. PubMed ID: 16159094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy.
    Ridolfo AL; Resta F; Milazzo L; Caramma I; Matacena G; Antinori S; Galli M
    Clin Infect Dis; 2008 Jan; 46(2):e19-22. PubMed ID: 18171242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.